Assembly Biosciences Inc.

0.8500-0.0350-3.95%Vol 86.16K1Y Perf -46.04%
Oct 2nd, 2023 16:00 DELAYED
BID0.8220 ASK0.9191
Open0.8700 Previous Close0.8850
Pre-Market- After-Market0.82
 - -  -0.03 -3.27%
Target Price
2.38 
Analyst Rating
Moderate Buy 2.33
Potential %
180.00 
Finscreener Ranking
     41.43
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     48.82
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     40.53
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
7.84 
Earnings Rating
Strong Buy
Market Cap44.72M 
Earnings Date
14th Nov 2023
Alpha-0.05 Standard Deviation0.19
Beta0.74 

Today's Price Range

0.82000.8850

52W Range

0.77001.79

5 Year PE Ratio Range

-7.70-4.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.61%
1 Month
-13.27%
3 Months
-20.56%
6 Months
1.31%
1 Year
-46.04%
3 Years
-94.86%
5 Years
-97.34%
10 Years
-94.77%

TickerPriceChg.Chg.%
ASMB0.8500-0.0350-3.95
AAPL173.752.54001.48
GOOG135.173.32002.52
MSFT321.806.05001.92
XOM115.63-1.9500-1.66
WFC39.61-1.2500-3.06
JNJ155.15-0.6000-0.39
FB196.640.99000.51
GE108.79-1.7600-1.59
JPM143.77-1.2500-0.86
ValuationValueIndustryS&P 500US Markets
-0.50
0.66
12.86
414.90
-1.00
-1.78
0.66
2.10
-37 045 600.00
Forward PE-0.90
PEG-
Financial StrengthValueIndustryS&P 500US Markets
7.10
7.40
0.01
0.04
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-
-1 404.90
-1 397.20
-798.50
-81.40
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-19.22
43.16
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.29-0.32-10.34
Q01 2023-0.37-0.370.00
Q04 2022-0.56-0.4617.86
Q03 2022-0.47-0.48-2.13
Q02 2022-0.49-0.51-4.08
Q01 2022-0.49-0.482.04
Q04 2021-0.50-0.4118.00
Q03 2021-0.55-0.4125.45
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.238.00Positive
12/2023 QR-0.2212.00Positive
12/2023 FY-1.152.54Positive
12/2024 FY-0.98-22.50Negative
Next Report Date14th Nov 2023
Estimated EPS Next Report-0.23
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume86.16K
Shares Outstanding52.61K
Shares Float50.30M
Trades Count424
Dollar Volume74.26K
Avg. Volume91.05K
Avg. Weekly Volume75.70K
Avg. Monthly Volume101.06K
Avg. Quarterly Volume96.40K

Assembly Biosciences Inc. (NASDAQ: ASMB) stock closed at 0.85 per share at the end of the most recent trading day (a -3.95% change compared to the prior day closing price) with a volume of 86.16K shares and market capitalization of 44.72M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 120 people. Assembly Biosciences Inc. CEO is John G. McHutchison.

The one-year performance of Assembly Biosciences Inc. stock is -46.04%, while year-to-date (YTD) performance is -34.62%. ASMB stock has a five-year performance of -97.34%. Its 52-week range is between 0.77 and 1.79, which gives ASMB stock a 52-week price range ratio of 7.84%

Assembly Biosciences Inc. currently has a PE ratio of -0.50, a price-to-book (PB) ratio of 0.66, a price-to-sale (PS) ratio of 12.86, a price to cashflow ratio of 414.90, a PEG ratio of -, a ROA of -78.79%, a ROC of -77.68% and a ROE of -89.48%. The company’s profit margin is -81.40%, its EBITDA margin is -1 397.20%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Assembly Biosciences Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. Assembly Biosciences Inc.’s next earnings report date is 14th Nov 2023.

The consensus rating of Wall Street analysts for Assembly Biosciences Inc. is Moderate Buy (2.33), with a target price of $2.38, which is +180.00% compared to the current price. The earnings rating for Assembly Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Assembly Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Assembly Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.85, ATR14 : 0.06, CCI20 : -172.17, Chaikin Money Flow : 0.04, MACD : -0.03, Money Flow Index : 48.50, ROC : -5.56, RSI : 37.69, STOCH (14,3) : 15.00, STOCH RSI : 0.00, UO : 37.76, Williams %R : -85.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Assembly Biosciences Inc. in the last 12-months were: Delaney William (Sold 23 675 shares of value $24 004 ), Jason A. Okazaki (Sold 4 693 shares of value $4 785 ), Mchutchison John (Sold 40 855 shares of value $39 215 ), Okazaki Jason (Sold 15 501 shares of value $15 093 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (25.00 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
3 (75.00 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.33
Moderate Buy
2.50
Moderate Buy
2.50

Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

CEO: John G. McHutchison

Telephone: +1 833 509-4583

Address: 331 Oyster Point Blvd, South San Francisco 94080, CA, US

Number of employees: 120

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

Bearish Bullish

62%38%

 

News

Stocktwits